Geographic · Total long-lived assets
Europe — Total long-lived assets
AbbVie Europe — Total long-lived assets increased by 21.5% to $1.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.5%, from $1.49B to $1.80B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ4 2025Feb 20, 2026
Rolls up toPP&E (Net)
How to read this metric
An increase typically indicates significant capital investment or acquisitions within the region, while a decrease may suggest asset divestitures, impairment charges, or the depreciation of existing infrastructure.
Detailed definition
This metric represents the total carrying value of non-current, tangible, and intangible assets located within the Europ...
Peer comparison
Peer pharmaceutical companies report similar geographic breakdowns of long-lived assets to demonstrate regional capital intensity and the concentration of manufacturing or R&D infrastructure.
Metric ID:
abbv_segment_europe_total_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.40B | $1.37B | $1.43B | $1.49B | $1.80B |
| QoQ Change | — | -2.2% | +4.7% | +3.6% | +21.5% |
| YoY Change | — | -2.2% | +4.7% | +3.6% | +21.5% |
Range$1.37B – $1.80B
CAGR+28.9%
Avg YoY Growth+6.9%
Median YoY Growth+4.2%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's europe — total long-lived assets?
- AbbVie (ABBV) reported europe — total long-lived assets of $1.80B in Q4 2025.
- How has AbbVie's europe — total long-lived assets changed year-over-year?
- AbbVie's europe — total long-lived assets increased by 21.5% year-over-year, from $1.49B to $1.80B.
- What does europe — total long-lived assets mean?
- The total value of long-term assets, such as facilities and intellectual property, held by the company within its European operations.